- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, September 15, 2017
Coverage of our peer-reviewed research in the healthcare and mainstream press.
New research about overtreatment in US healthcare published in PLOS One cited a study from The American Journal of Managed Care® (AJMC®) as a reference. “Cervical Cancer Screening Overuse and Underuse: Patient and Physician Factors,” published in the June 2013 issue of AJMC®, found that overuse of these tests is common and can be linked to patient and clinician factors. The AJMC® newsroom recently featured an article covering the findings of the PLOS One study on unnecessary medical care.
An article from the AJMC® newsroom was highlighted in the National Pharmaceutical Council’s Wednesday e-newsletter. The story, “New Value-Based Insurance Plan Helps Consumers Who Use Healthcare the Most,” covered an innovative plan announced by Altarum that will use reference pricing to encourage consumers to seek high-value care. A. Mark Fendrick, MD, director of the University of Michigan Center for Value-Based Insurance Design and co-editor-in-chief of AJMC®, explained that the model could align consumer and provider incentives on quality and cost.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More
